These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 457495)

  • 21. The combination of the tetrazolium derivative reduction (MTT) and digital cell image analysis to monitor in vitro the cytotoxicity of anti-neoplastic drugs.
    Etievant C; Kruczynski A; Pauwels O; Kiss R
    Anticancer Res; 1991; 11(1):305-11. PubMed ID: 2018364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microbial iron chelator-induced cell cycle synchronization in L1210 cells: potential in combination chemotherapy.
    Bergeron RJ; Ingeno MJ
    Cancer Res; 1987 Nov; 47(22):6010-6. PubMed ID: 3664504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-1 modulatory effect on the action of chemotherapeutic drugs and localized irradiation of the lip, duodenum, and tumor.
    Zaghloul MS; Dorie MJ; Kallman RF
    Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):417-25. PubMed ID: 8514539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Damage and recovery assessment of the mouse jejunum to abdominal X-ray and adriamycin treatment.
    Burholt DR; Hagemann RF; Cooper JW; Schenken LL; Lesher S
    Br J Radiol; 1975 Nov; 48(575):908-12. PubMed ID: 1218300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of K-Ras mutant frequency and micronucleus incidence in the mouse duodenum following 90-days of exposure to Cr(VI) in drinking water.
    O'Brien TJ; Ding H; Suh M; Thompson CM; Parsons BL; Harris MA; Winkelman WA; Wolf JC; Hixon JG; Schwartz AM; Myers MB; Haws LC; Proctor DM
    Mutat Res; 2013 Jun; 754(1-2):15-21. PubMed ID: 23583686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective antiproliferative effects of thymidine.
    Ooi SO; Sim KY; Chung MC; Kon OL
    Experientia; 1993 Jul; 49(6-7):576-81. PubMed ID: 8335084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential responses of proliferating versus quiescent cells to adriamycin.
    Siu WY; Arooz T; Poon RY
    Exp Cell Res; 1999 Jul; 250(1):131-41. PubMed ID: 10388527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adriamycin damage: in vivo repair by lymphoma cells.
    Potmesil M; Levin M; Goldfeder A; Silber R
    J Natl Cancer Inst; 1981 Dec; 67(6):1259-63. PubMed ID: 6947109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytostatic action of methylmercuric chloride on mammalian duodenal cells.
    Curle DC; Ray M; Persaud TV; Bertalanffy FD
    Histol Histopathol; 1987 Jul; 2(3):223-6. PubMed ID: 2980724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of an antitumor chelator, 2-(2-hydroxy-5-n-hexylphenyl)-8-quinolinol-4-carboxylic acid (HQ-II) on DNA synthesis, clonogenicity, and cell cycle progression of HeLa cells.
    Ujiie T
    Jpn J Exp Med; 1987 Feb; 57(1):19-30. PubMed ID: 3114517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of adriamycin on the cell cycle traverse and kinetics of cultured human lymphoblasts.
    Krishan A; Frei E
    Cancer Res; 1976 Jan; 36(1):143-50. PubMed ID: 1247994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of murine intestinal stem cell survival after irradiation by keratinocyte growth factor.
    Khan WB; Shui C; Ning S; Knox SJ
    Radiat Res; 1997 Sep; 148(3):248-53. PubMed ID: 9291356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flow cytometric analysis of adriamycin-perturbed mouse mammary tumors.
    Dethlefsen LA; Riley RM; Roti Roti JL
    J Histochem Cytochem; 1979 Jan; 27(1):463-9. PubMed ID: 374611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The interaction between radiation and adriamycin damage in mammalian cells.
    Belli JA; Piro AJ
    Cancer Res; 1977 Jun; 37(6):1624-30. PubMed ID: 870177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacodynamic model describing the growth of a mammary carcinoma in the mouse under the influence of adriamycin treatment.
    Dagnino G; Donelli MG; Colombo T; Bertello C; Pacciarini MA; Martini A
    Oncology; 1981; 38(1):53-8. PubMed ID: 7443177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of adriamycin on the cell kinetics of 13762 rat mammary tumors and implications for therapy.
    Braunschweiger PG; Schiffer LM
    Cancer Treat Rep; 1980; 64(2-3):293-300. PubMed ID: 7407764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic energy availability and proliferative activity in adriamycin-treated cells.
    Prosperi E; Croce AC; Supino R; Bottiroli G
    Anticancer Res; 1989; 9(1):203-7. PubMed ID: 2705748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cystic fibrosis transmembrane conductance regulator and Na+ channel subunits mRNA transcripts, and Cl- efflux, show a different distribution in rat duodenum and colon.
    Odes HS; Smirnoff P; Guberman R; Pollak-Charcon S; Sperber AD; Fich A; Fraser GM; Schwartz B
    Acta Physiol Scand; 2003 Jul; 178(3):231-40. PubMed ID: 12823181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delayed enhanced effects of Adriamycin on the X-irradiation-induced gastrointestinal toxicity in mice.
    Dethlefsen LA; Riley RM; Lehman CM
    Radiat Res; 1984 Oct; 100(1):157-70. PubMed ID: 6387775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of tumor growth inhibitory activity of macrophages exposed to adriamycin and adriamycin sensitivity of the target tumor cells.
    Giavazzi R; Bucana CD; Hart IR
    J Natl Cancer Inst; 1984 Aug; 73(2):447-55. PubMed ID: 6589436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.